Yamin Khan
Chief Executive Officer presso HVIVO PLC
Patrimonio netto: 190 133 $ in data 31/03/2024
Profilo
Yamin Mohammed Khan's current job is Chief Executive Officer & Director at hVIVO PLC.
He also holds the position of EVP-Global Clinical Development at Pharm-Olam International Ltd.
Mr. Khan's former job was Chief Revenue Officer at Pharm-Olam International (UK) Ltd.
Mr. Khan has an undergraduate degree from The University of Liverpool and a doctorate degree from The University of Southampton.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
HVIVO PLC
0.07% | 31/12/2022 | 510 204 ( 0.07% ) | 190 133 $ | 31/03/2024 |
Posizioni attive di Yamin Khan
Società | Posizione | Inizio |
---|---|---|
HVIVO PLC | Chief Executive Officer | 24/02/2022 |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | Corporate Officer/Principal | 11/11/2009 |
Precedenti posizioni note di Yamin Khan
Società | Posizione | Fine |
---|---|---|
Pharm-Olam International (UK) Ltd.
Pharm-Olam International (UK) Ltd. BiotechnologyHealth Technology Part of Shomer XV Ltd., Pharm-Olam International (UK) Ltd. is a clinical research organization that specializes in solving distinct challenges of small and mid-sized biopharma companies. The private company is based in Bracknell, UK and operates under the name allucent. The British company offers contract research services and clinical expertise to ensure the success of their clients' products. The company's resource center provides the latest articles, blogs, brochures, and videos from their experts. | Corporate Officer/Principal | 01/01/2019 |
Formazione di Yamin Khan
The University of Liverpool | Undergraduate Degree |
The University of Southampton | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
HVIVO PLC | Commercial Services |
Aziende private | 2 |
---|---|
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | Commercial Services |
Pharm-Olam International (UK) Ltd.
Pharm-Olam International (UK) Ltd. BiotechnologyHealth Technology Part of Shomer XV Ltd., Pharm-Olam International (UK) Ltd. is a clinical research organization that specializes in solving distinct challenges of small and mid-sized biopharma companies. The private company is based in Bracknell, UK and operates under the name allucent. The British company offers contract research services and clinical expertise to ensure the success of their clients' products. The company's resource center provides the latest articles, blogs, brochures, and videos from their experts. | Health Technology |
- Borsa valori
- Insiders
- Yamin Khan